Patents for A61P 23 - Anaesthetics (4,141)
09/1999
09/14/1999US5952369 Pyrrolidinyl hydroxamic acid compounds and their production process
09/14/1999CA2153264C New cyclopropyl derivatives, preparation method thereof and applications
09/01/1999EP0691842B1 Lidocaine aerosol anaesthetic
08/1999
08/31/1999US5945435 Levobupivacaine and its use
08/24/1999US5942497 Purine compound and catecholamine compound containing compositions and methods for administration
08/12/1999WO1999039712A1 Substituted semicarbazides and the use thereof
08/12/1999WO1999039696A1 Propofol composition containing sulfite
08/12/1999CA2319484A1 Substituted semicarbazides and the use thereof
08/11/1999EP0934264A1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
08/03/1999US5932597 Anaesthetic formulation
08/03/1999US5932236 Pharmaceutical composition and methods for using it
07/1999
07/29/1999WO1999037301A1 New use for pain management
07/22/1999WO1999036478A1 Color shifting film glitter
07/22/1999WO1999036421A1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
07/22/1999WO1999036071A1 Biodegradable polymer matrices for sustained delivery of anesthetics
07/06/1999US5919804 Use of levobupivacaine in facial surgery
07/06/1999US5919798 4-heteroaryl-1-piperidinealkanols and derivatives thereof and their therapeutic utility
07/06/1999US5919479 Noninvasive dermal anesthetics
07/01/1999WO1999032431A1 A NOVEL PHOSPHATE SALT OF ISOPROPYL-METHYL-[2-(3-n-PROPOXYPHENOXY)ETHYL]AMINE
07/01/1999WO1999032430A1 Process for the preparation of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine
07/01/1999CA2314989A1 A novel phosphate salt of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine
07/01/1999CA2314988A1 Process for the preparation of isopropyl-methyl-¬2-(3-n-propoxyphenoxy)ethyl|amine
06/1999
06/16/1999CN1219391A Choline antagonist sticking preparation
06/09/1999CN1218664A Method for preparing butethanol of injection
06/08/1999US5910502 Use of levobupivacaine in paediatric surgery
06/03/1999WO1999026614A1 Substituted 2-aminoacetamides and the use thereof
06/02/1999CN1218398A Proopofol microdroplet formulations
05/1999
05/27/1999WO1999025349A1 Anaesthetic formulation
05/14/1999WO1999022717A1 Novel formulation for use in pain management
05/14/1999CA2309122A1 Novel formulation for use in pain management
05/12/1999EP0914107A1 Compositions comprising lidocaine and emu oil and methods of use thereof
05/12/1999EP0735888A4 Purine compositions and methods for administration
05/06/1999WO1999008729A9 Loading and release of water-insoluble drugs
04/1999
04/27/1999US5898035 A pharmaceutical formulation for the intravenous regional sympathetic blockade treatment comprising an adrenergic blocking agent and pain reliever for reducing hypotensive side-effect
04/21/1999EP0909184A2 Targeted drug delivery using sulfonamide derivatives
04/08/1999WO1999004772A3 Use of levobupivacaine
04/08/1999WO1999004771A3 Use of levobupivacaine
04/07/1999EP0877026A4 Substituted 6-r-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
03/1999
03/31/1999EP0904083A1 Anesthetic method
03/31/1999EP0904055A2 Buccal, non-polar spray or capsule
03/31/1999EP0877025A4 Substituted 6-h-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
03/30/1999US5889035 1-(Arylthioalkyl, arylaminoalkyl or arylmethylenealkyl)-3-(heteroaryl) pyrrolidines and related compounds useful as antipsychotics and analgesics
03/30/1999US5889004 4-heteroaryl-1-piperazinealkylthiols and derivatives thereof and their therapeutic utility
03/25/1999WO1999013865A1 Sustained-release liposomal anesthetic compositions
03/18/1999WO1999012523A1 Modulation of drug loading in multivesicular liposomes
03/18/1999WO1999012521A1 New foam-forming pharmaceutical composition
03/18/1999CA2302710A1 New foam-forming pharmaceutical composition
02/1999
02/25/1999WO1999008729A1 Loading and release of water-insoluble drugs
02/25/1999CA2298543A1 Loading and release of water-insoluble drugs
02/23/1999US5874435 Psychological disorders; analgesics
02/04/1999WO1999004772A2 Use of levobupivacaine
02/04/1999WO1999004771A2 Use of levobupivacaine
02/03/1999EP0763038B1 The preparation of nalbuphine having low levels of beta-epimer
01/1999
01/28/1999WO1999003473A1 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
01/26/1999US5863560 Compositions and methods for topical application of therapeutic agents
01/21/1999WO1999002252A1 Improvements in or relating to capsules
01/20/1999CN1205699A 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
01/14/1999WO1999001114A1 Prolonged anesthesia in joints and body spaces
01/12/1999US5858388 Matrix of ethylene-vinyl acetate copolymer, hydromorphone embedded homogeneously in matrix and biocompatible, non-biodegradable polymer coating
12/1998
12/29/1998US5854412 Chemokine N-terminal deletion mutations
12/29/1998US5854263 1- (1,4-benzodioxanyl)alkyl!-3-(heteroaryl) pyrrolidines and related compounds and their therapeutic utility
12/29/1998US5854243 3-heteroaryl-1-pyrrolidinealkylthiols and derivatives thereof and their therapeutic utility
12/29/1998US5853732 Pharmaceutical compositions containing kukui nut oil
12/23/1998WO1998057643A1 Use of draflazine-analogues for treating pain
12/23/1998CA2294011A1 Use of draflazine-analogues for treating pain
12/15/1998US5849334 Composition comprising a local anesthetic and emu oil and methods of use thereof
12/08/1998US5846975 Use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
12/03/1998WO1998053805A1 Clear, injectable formulation of an anesthetic compound
12/03/1998CA2291261A1 Clear, injectable formulation of an anesthetic compound
12/02/1998CN1200723A New (3-alkoxy-phenoxy)-ethyl] dialkylamine derivatives and their use as local anaesthetics
12/01/1998US5843977 (3-heteroaryl-1-pyrrolidinyl) alkoxy!-3,4-dihydro-1(2H)-naphthalenones and related compounds and their therapeutic utility
12/01/1998US5843949 1-(1H-indolyloxyalkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics
11/1998
11/25/1998CN1200017A Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
11/24/1998US5840727 (4-heteroaryl)-1- (2,3-dihydro-1H-isoindol-2-yl) alkyl! piperazines and related compounds and their therapeutic utility
11/11/1998EP0877026A1 Substituted 6-r-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
11/11/1998EP0877025A1 Substituted 6-h-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
11/10/1998US5834489 Continuous epidural infusion, minimal motor blockade, anesthetics
11/10/1998US5834478 Morphinan hydroxamic acid compounds
11/10/1998US5834010 Triacetin as a penetration enhancer for transdermal delivery of a basic drug
11/04/1998CN1197636A Freezing-dried tetracaine hydrochloride powder injection
10/1998
10/29/1998WO1998047869A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/29/1998CA2287255A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/22/1998WO1998046235A1 Analgesic combination
10/22/1998DE19715594A1 Analgetika-Kombination Analgesic combination
10/21/1998EP0871420A1 Triacetin as a transdermal penetration enhancer
10/07/1998EP0869119A1 Phenoxymethyl piperidine derivatives being sodium channle blockers
10/07/1998CN1194977A Phenoxymethyl piperidine derivatives
10/03/1998CA2232147A1 Phenoxymethyl piperidine derivatives
10/01/1998WO1998042675A1 Substituted isoquinolines as ultra short acting neuromuscular blockers
10/01/1998WO1998042674A1 Substituted isoquinolines as ultra short acting neuromuscular blockers
09/1998
09/22/1998US5811435 2- (4-heteroaryl-1-piperidinyl)alkyl!-1,3-dioxanes and related compounds and their therapeutic utility
09/22/1998US5811430 1 (2-pyrimidinyloxy) alkyl!-4- (heteroaryl) Piperidines and related compounds and their therapeutic utility
09/17/1998WO1998040070A1 Compositions containing capsaicin or capsaicin analogues and a local anesthetic
09/17/1998CA2283227A1 Medicinal preparation containing a lipophilic inert gas
09/16/1998CN1193275A Percutaneous tap preparation containing fentanyl
09/11/1998WO1998038999A1 The use of levobupivacaine in paediatric surgery
09/11/1998WO1998038996A1 The use of levobupivacaine in facial surgery
09/11/1998WO1998038854A1 Pharmaceutical composition and methods for using it
09/09/1998EP0862566A1 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
09/03/1998WO1998038165A1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42